Synergizing Organoid and CRISPR Technologies: Pioneering a New Era in Biomedical Research
Journal of Organoid and Bioscience · 2023
DOI: 10.62714/vjyl5292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Organoid and Bioscience, 2023. Verfasst von Flora Wang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Organoids have emerged as a groundbreaking technique in biomedical research. Leveraging clinical samples, they enable the rapid creation of in vitro models that faithfully preserve the pathological, genetic, and epigenetic features of patient samples, thereby illuminating preclinical research. CRISPR, a well-established technique, empowers precise genetic manipulation on a large scale. The combination of these techniques enables researchers to simultaneously manipulate thousands of genes and assess their impact on phenotypes. In this study, we analyze several papers that integrate organoids and CRISPR techniques to identify key factors in development or pathogenesis.
Zitieren
APA
Wang, F., & Liu, S. (2023). Synergizing Organoid and CRISPR Technologies: Pioneering a New Era in Biomedical Research. Journal of Organoid and Bioscience. https://doi.org/10.62714/vjyl5292
Vancouver
Wang F, Liu S. Synergizing Organoid and CRISPR Technologies: Pioneering a New Era in Biomedical Research. Journal of Organoid and Bioscience. 2023. doi:10.62714/vjyl5292
BibTeX
@article{Wang2023,
author = {Wang, Flora and Liu, Samuel},
title = {Synergizing Organoid and CRISPR Technologies: Pioneering a New Era in Biomedical Research},
journal = {Journal of Organoid and Bioscience},
year = {2023},
doi = {10.62714/vjyl5292}
}
EUVIMED